Works matching DE "FINGOLIMOD"

Results: 664
    1
    2
    3
    4
    5
    6
    7

    Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE).

    Published in:
    Turkish Journal of Medical Sciences, 2023, v. 53, n. 1, p. 323, doi. 10.55730/1300-0144.5588
    By:
    • TUNCER, Aslı;
    • KÜRTÜNCÜ, Murat;
    • TERZİ, Murat;
    • UYGUNOĞLU, Uğur;
    • GÖNCÜOĞLU, Cansu;
    • YÜCEYAR, Ayşe Nur;
    • EKMEKÇİ, Özgül;
    • TÜRKOĞLU, Recai;
    • SOYSAL, Aysun;
    • KÖSEOĞLU, Mesrure;
    • BOZ, Cavit;
    • BECKMANN, Yeşim;
    • TURAN, Ömer Faruk;
    • DEMİRKIRAN, Meltem;
    • AKMAN, Gülşen;
    • ALTUNRENDE, Burcu;
    • AYDIN CANTÜRK, İlknur;
    • BİRDAY, Erkingül;
    • ÖZCAN, Abdulcemal;
    • KAMIŞLI, Özden
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Immunophenotype and Transcriptome Profile of Patients With Multiple Sclerosis Treated With Fingolimod: Setting Up a Model for Prediction of Response in a 2-Year Translational Study.

    Published in:
    Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01693
    By:
    • Moreno-Torres, Irene;
    • González-García, Coral;
    • Marconi, Marco;
    • García-Grande, Aranzazu;
    • Rodríguez-Esparragoza, Luis;
    • Elvira, Víctor;
    • Ramil, Elvira;
    • Campos-Ruíz, Lucía;
    • García-Hernández, Ruth;
    • Al-Shahrour, Fátima;
    • Fustero-Torre, Coral;
    • Sánchez-Sanz, Alicia;
    • García-Merino, Antonio;
    • Sánchez López, Antonio José
    Publication type:
    Article
    21

    Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid—Results from the ToFingo Successor Study

    Published in:
    Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01560
    By:
    • Lohmann, Lisa;
    • Janoschka, Claudia;
    • Schulte-Mecklenbeck, Andreas;
    • Klinsing, Svenja;
    • Kirstein, Lucienne;
    • Hanning, Uta;
    • Wirth, Timo;
    • Schneider-Hohendorf, Tilman;
    • Schwab, Nicholas;
    • Gross, Catharina C.;
    • Eveslage, Maria;
    • Meuth, Sven G.;
    • Wiendl, Heinz;
    • Klotz, Luisa
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Clinical studies and anti-inflammatory mechanisms of treatments.

    Published in:
    Epilepsia (Series 4), 2017, v. 58, p. 69, doi. 10.1111/epi.13779
    By:
    • French, Jacqueline A.;
    • Koepp, Matthias;
    • Naegelin, Yvonne;
    • Vigevano, Federico;
    • Auvin, Stéphane;
    • Rho, Jong M.;
    • Rosenberg, Evan;
    • Devinsky, Orrin;
    • Olofsson, Peder S.;
    • Dichter, Marc A.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod.

    Published in:
    Molecules, 2020, v. 25, n. 1, p. 20, doi. 10.3390/molecules25010020
    By:
    • Cavalli, Eugenio;
    • Mazzon, Emanuela;
    • Basile, Maria Sofia;
    • Mammana, Santa;
    • Pennisi, Manuela;
    • Fagone, Paolo;
    • Kalfin, Reni;
    • Martinovic, Vanja;
    • Ivanovic, Jovana;
    • Andabaka, Marko;
    • Mesaros, Sarlota;
    • Pekmezovic, Tatjana;
    • Drulovic, Jelena;
    • Nicoletti, Ferdinando;
    • Petralia, Maria Cristina
    Publication type:
    Article